2019 Research Highlight
PSA screening - for whom and when? Peter Albers Asian J Androl : 3-5; 10.4103/aja.aja_37_17 Abstract |Full Text | PDF [1900]
Current and emerging trends in prostate cancer immunotherapy Adam Schatz, Badar M Mian Asian J Androl : 6-11; 10.4103/aja.aja_52_17 Abstract |Full Text | PDF [1921]
Enzalutamide: a new indication for nonmetastatic castration-resistant prostate cancer Logan P Rhea1, Brinda Gupta2, Jeanny B Aragon-Ching3 Asian J Androl : 107-108; 10.4103/aja.aja_88_18 Full Text | PDF [1455]
|